ReviewCurrent oncology reports2026

Utilization of Steroid Sparing Agents for Immune-Related Adverse Events (irAEs): Management Strategies and Considerations.

Sherin J Rouhani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.